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Abstract
Background: The age of menarche has been associated with metabolic and cardiovascular disease, as well as cancer
risk. The decline in menarcheal age over the past century may be partially attributable to increased exposure to
endocrine disrupting chemicals (EDCs).
Methods: We assessed the influence of 26 phenol and phthalate biomarkers on the timing of menarche in a longitudinal
cohort of Chilean girls. These EDCs were quantified in urine collected prior to the onset of breast development (Tanner 1;
B1), and during adolescence (Tanner 4; B4). Multivariable accelerated failure time (AFT) models were used to analyze
associations between biomarker concentrations and the age of menarche adjusting for body mass index (BMI) Z-score
and maternal education, accounting for within-subject correlation.
Results: Several biomarkers were significantly associated with the age at menarche; however, these associations were
dependent on the timing of biomarker assessment. A log(ng/ml) increase in B1 concentrations of di(2-ethylhexyl)
phthalate biomarkers was associated with later menarche (hazard ratio (HR): 0.77; 95% CI: 0.60, 0.98), whereas
higher B1 concentrations of 2,5-dichlorophenol and benzophenone-3 were associated with earlier menarche (HR:
1.13; 95% CI: 1.01, 1.27; HR: 1.17; 95% CI: 1.06, 1.29, respectively). Elevated B4 concentrations of monomethyl
phthalate were similarly associated with earlier menarche (HR: 1.30; 95% CI: 1.10, 1.53). The impact of monoethyl
phthalate and triclosan concentrations on pubertal timing were significantly modified by BMI Z-score. Higher
monoethyl phthalate and triclosan concentrations were associated with earlier menarche among overweight or
obese girls, but not among those that were normal weight.
Conclusions: This study identifies modulation of sexual maturation by specific EDC biomarkers in Latina girls.
Keywords: Menarche, Puberty, Phenols, Phthalates, Endocrine disrupting chemicals
Background
Determinants of pubertal timing are of public health
concern because of the association between the age of
onset and adult disease susceptibility. Among females,
early menarche has been associated with an increased
risk of type 2 diabetes, cardiovascular disease, and repro-
ductive cancers, including breast [1–3]. The average age
of menarche has decreased from 16-17 years at the end
of the nineteenth century, to less than 13 years across
Europe and the United States, likely due to improve-
ments in nutrition and general health [4, 5]. While the
age of menarche was thought to have stabilized in the
past 50 years, more recent studies have suggested that
the age of menarche has continued to decline in South
America, the United States, and many countries in Eur-
ope [6–9]. The secular trend towards earlier menarche
has been observed across race/ethnicity groups, despite
differences in timing [7, 10–12]. Within the United
States, the average age of menarche is earlier among
Hispanic and black females relative to white females,
adjusting for BMI, as well as social and economic
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indicators [7, 13]. Across Europe and South America,
the fastest decline has been among impoverished girls,
in spite of earlier menarche being previously more com-
mon among affluent families [6, 8, 9, 14, 15].
The two primary hypotheses for this shift towards earl-
ier menarche are the growing childhood obesity epidemic
and increasing exposure to endocrine disruptor chemicals
(EDCs) [16–18]. EDCs can influence the endocrine system
through a multitude of mechanisms, including competi-
tive binding to hormone receptors to modulation of hor-
mone synthesis and metabolism [19]. There is building
evidence that EDCs can affect proper function across a
number of different tissues, including breast tissue and fe-
male reproductive organs [19], as well as influencing the
neuroendocrine control of reproduction. Results of both
in vivo studies and a few longitudinal human cohorts sug-
gest some of these compounds may be obesogenic, with
early life exposure associated with childhood body size
[20–23]. Phenols and phthalates are two classes of EDCs
of particular concern due to their use in an extensive array
of products, including plastics, building materials, per-
sonal care products, insecticides, and herbicides [24]. In
this study, we analyzed the association between pre-
pubescent and pubescent biomarkers of exposure to select
phenols and phthalates and the timing of menarche within
a longitudinal cohort of Chilean girls born in 2002–2003.
Two cross-sectional studies and four longitudinal studies
have analyzed the influence of childhood EDC exposure
on the age of menarche [25–30]. The results of these
studies have been largely discordant, potentially reflecting
regional and socioeconomic influences on exposure
profile, differences in the age of biomarker measurement,
and possible effect modification by race/ethnicity. For this
study, we quantified a broad panel of 26 phenol and
phthalate urinary biomarker concentrations prior to the
onset of breast development (Tanner 1; B1) and at Tanner
4 (B4). This study provides unique insight into the
influence of these compounds on pubertal timing in
Latina girls.
Methods
Study population
Our study population was a random subset of 200 girls
part of the longitudinal Growth and Obesity Cohort
Study (GOCS) with urine samples collected at B1 (ages
6.7 to 9.6 years; median age: 7.9 years) and B4 (ages 9.4
to 13.1 years; median age: 11.2 years). The GOCS chil-
dren were born in 2002–2003, and are representative of
the low to middle-income families in Santiago, Chile. A
description of the cohort has been provided elsewhere
[31]. Starting in 2009, breast development was assessed
by two trained dietitians (kappa with pediatric endocrin-
ologist = 0.85) by visual inspection using Tanner’s rating
scale approximately every 6 months [32]. Palpation was
additionally used to distinguish breast Tanner 1 from
Tanner 2. Sex and age-adjusted BMI Z-score at each visit
were calculated based on the Centers for Disease
Control and Prevention (CDC) growth charts. Girls were
categorized as having excess weight (overweight or
obese) if their BMI Z-score was equal or above the 85th
percentile. Informed consent was obtained from all par-
ents or guardians of children before the start of data
collection.
Biomarker measurements
Fasting spot urine samples were collected between
10 AM and 12 PM in polypropylene sterile cups, and
were immediately vortexed and aliquoted. Concentra-
tions of 26 phenol and phthalate biomarkers were quan-
tified in urines collected at breast Tanner 1 (B1) and
Tanner 4 (B4) from 200 girls (400 samples). The analyt-
ical measurements were performed at the CDC National
Center for Environmental Health Laboratory using pre-
viously described analytical methods [33, 34]. Concen-
trations below the limit of detection (LOD) were given
an imputed value equal to LOD/sqrt(2) [35]. Biomarker
concentrations (ng/ml) were corrected for specific grav-
ity. Dilution adjustment was performed using the for-
mula Pc = P[(1.015–1)/(SG-1)], where Pc is the specific
gravity-corrected biomarker concentration, P is the ob-
served biomarker concentration, SG is the specific grav-
ity of the urine sample, and 1.015 is the median SG of
the study population [36, 37]. To calculate the summa-
tion of di(2-ethylhexyl) phthalate (DEHP) metabolites
( DEHP), concentrations of MEHP, MEOHP, MEHHP,
and MECPP were converted to nmol/L before being
added together. The analysis of blinded specimens by
the CDC laboratory was determined not to constitute
engagement in human subjects’ research.
Age of menarche
Prior to the onset of B4, girls were asked to report the date
of their first menstrual bleeding at each 6-month visit.
After achieving B4, girls were contacted by study dieticians
every 3 months to survey whether the girl had reached
menarche. During this phone interview, a questionnaire
was used to differentiate menarche from other potential
causes of vaginal bleeding, such as vaginal infection, urin-
ary infection or trauma. Longitudinal follow-up of partici-
pants enabled the confirmation of menarche onset.
Statistical methods
Multivariable accelerated failure time (AFT) models
were used to assess the influence of individual phenol
and phthalate biomarker concentrations on time to me-
narche, assuming a Weibull distribution. To account for
possible confounding by body size, models were adjusted
for BMI Z-score at EDC measurement [16–18, 38, 39].
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Models were additionally adjusted for maternal educa-
tion as an indicator of socioeconomic status, which is re-
lated to both exposure profile and age of menarche [6, 8,
9, 14, 15, 40]. Sensitivity analyses were conducted fur-
ther adjusting for the mother’s age of menarche (recall;
≤11, 12, 13,≥14 years), which may capture confounding
by transgenerational exposures correlated with socioeco-
nomic status. These analyses were restricted to the sub-
set of the families that reported mother’s age of
menarche (N = 181), assuming recall data was missing
completely at random. A cluster statement was used to
account for within-subject correlation between B1 and
B4 biomarker measurements. Accordingly, inference was
based on robust standard errors estimated using the Hu-
ber sandwich estimator. For incident cases, survival time
was the age at menarche, estimated based on time be-
tween the self-reported date of first menses and date of
birth. Survival time for right censored individuals was
the age at last clinic visit, based on the time between
date of last visit and date of birth. Time-varying associa-
tions between biomarker concentration (log(ng/ml)) and
the age of menarche were investigated by adding Tanner
stage as well as an interaction between biomarker con-
centrations and Tanner stage to our models. Association
estimates from the AFT models were reported as the
relative change in hazard of menarche (hazard ratio;
HR) associated with a log(ng/ml) increase in biomarker
concentration, which generally corresponded to a change
from the lowest concentration quartile to the highest
quartile. If the interaction between Tanner stage and
concentration on timing of menarche was significant
(Wald test; p < 0.05), the reported associations were
stratified by Tanner stage. Similarly, a Wald test was
used to assess effect modification by BMI Z-score. If the
interaction term significantly improved model fit (p < 0.05),
the influence of the biomarker on the timing of menarche
was reported separately for overweight/obese girls and nor-
mal weight girls. To identify potential non-monotonic
dose-response relationships, we additionally modeled ter-
tiles of biomarker concentration, with tertile cut-points
stratified by Tanner stage. Significant trends across cat-
egories were evaluated by modeling the log(median)
concentration within tertiles as a continuous variable.
To visualize the change in the timing of menarche, we
computed median age at menarche for tertiles of urin-
ary concentrations using the baseline survivor function
of multivariable adjusted AFT models. All statistical
analysis was performed in R Version 3.3.1 and figures
were generated using ggplot2 [41].
Results
The influence of EDC exposure across childhood and
adolescence on the age of menarche was assessed among
200 Chilean girls born in 2002–2003. The median age at
urine collection prior to the onset of breast development
(B1) was 7.9 years and 11.2 years at Tanner 4 (Table 1).
Proportion of samples with measurements above the
limit of detection, as well as the geometric mean (95%
CI) biomarker concentrations at B1 and B4 are reported
in Additional file 1: Tables S1a and S1b. Analysis was re-
stricted to the subset of 21 biomarkers with detectable
concentrations at Tanner 1 and Tanner 4 in at least 75%
of the girls. These 21 biomarkers included: 2,4-dichloro-
phenol, 2,5-dichlorophenol, benzophenone-3, BPA, MBP,
MBzP, MCNP, MCOP, MCPP, MECPP, MEHHP, MEHP,
MEOHP, MEP, methyl paraben, MHBP, MHiBP, MiBP,
MMP, propyl paraben, triclosan; excluded were: MNP,
B-PB, BPF, BPS, and E-PB (see Abbreviation List;
Additional file 1: Table S1a and S1b). For reference, geo-
metric mean (95% CI) phenol and phthalate creatine-
adjusted urinary biomarker concentrations among U.S.
females of a similar age range from the 2011–2012
National Health and Nutrition Examination Survey are
reported in Additional file 1: Table S2. In both the U.S.
and Chilean populations, most biomarker concentra-
tions decreased with age (Additional file 1: Table S1a
and S1b; Additional file 1: Table S2). The intra-
Table 1 Study population characteristics
Characteristic Distribution
Age [years; median (range)]
At B1 EDC Measurement 7.9 (6.7–9.6)
At B4 EDC Measurement 11.2 (9.4–13.1)
Attained Menarche during Study Category [count (%)]
Yes 182 (91.0)
No 18 (9.0)
Age at Menarche [years; median (range)] 12.0 (9.4–13.8)
BMI Z-score [median (range)]
At B1 EDC Measurement 0.5 (−2.2–2.4)
At B4 EDC Measurement 0.5 (−2.7–2.2)
BMI Category [count (%)]
At B1 EDC Measurement
Under-weight or Normal weight (<85th Percentile) 147 (73.5)
Overweight or Obese (≥85th percentile) 53 (26.5)
At B1 EDC Measurement
Under-weight or Normal weight (<85th Percentile) 137 (68.5)
Overweight or Obese (≥85th percentile) 63 (31.5)
Height Z-score [median (range)]
At B1 EDC Measurement −0.1 (−2.6–2.1)
At B4 EDC Measurement 0.1 (−2.1–2.3)
Maternal Education [count (%)]
Post-Secondary Education 46 (23.0)
No Post-Secondary Education 154 (77.0)
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individual correlation between phenol and phthalate
biomarkers at B1 and B4 was moderate to low (Additional
file 1: Table S3). The mean age of menarche was 12.
0 years; the median age was similarly 12.0 years (95%
CI: 11.9–12.2 years). At the time of analysis, 18 girls
had not reached menarche or had dropped out of the
cohort. Of those that achieved menarche during the
course of the study, 10.5% (n = 21) reached menarche
prior to the first detection of B4. The occurrence of
menarche prior to B4 did not significantly modify the
linear association between any biomarkers and the age
of menarche in adjusted models. Therefore, B4 bio-
marker measurements for these 21 girls were included
in all subsequent models. Biomarker concentrations at
B1 were not significantly correlated with BMI Z-score.
Similarly, most B4 biomarker concentrations were not
correlated with B4 BMI Z-score, with the exception of
monoethyl phthalate (MEP) and 2,5-dichlorophenol,
which had moderate positive associations with BMI Z-
score (ρ = 0.21 and ρ = 0.22, respectively). Additional
study population characteristics are outlined in Table 1.
We did not detect a significant linear impact of aver-
age concentration across Tanner stages on the age of
menarche for any biomarker (Table 2). However, the as-
sociation between urinary biomarker concentrations and
the timing of menarche was significantly modified by the
Tanner stage at biomarker measurement for 2,5-dichlo-
rophenol, benzophenone-3, monomethyl phthalate
(MMP), and all of the metabolites of DEHP after adjusting
for BMI Z-score and maternal education (Table 2). Fur-
ther adjustment for mother’s age of menarche (≤11, 12,
13, ≥14 years) did not change the shape or strength of the
associations between EDC biomarker levels and daughter’s
age of menarche (Additional file 1: Tables S4 and S5). For
ease of interpretation, and to identify potential non-linear
influences, we evaluated the association between tertiles
of each biomarker and the timing of menarche in adjusted
models (Table 3; Fig. 1; T1=lowest tertile, T2=middle ter-
tile, T3=highest tertile). Among the subset of biomarkers
for which we did not detect significant effect modification
by Tanner stage at measurement, we found a non-
monotonic change in the timing of menarche between
Table 2 Menarche hazard ratio (95% CI) associated with log(ng/ml) increase in each EDC biomarker across puberty
Biomarker Unadjusted Model Adjusted Modela Interaction with Tanner stageb Interaction with BMIc
2,4-Dichlorophenol 0.98 (0.87, 1.10) 1.00 (0.89, 1.12) 0.246 0.062
2,5-Dichlorophenol 1.05 (0.97, 1.14) 1.04 (0.95, 1.14) 0.017* 0.975
Benzophenone-3 1.03 (0.97, 1.09) 1.05 (0.99, 1.11) 0.009** 0.235
BPA 0.90 (0.78, 1.05) 0.92 (0.79, 1.06) 0.362 0.790
MBP 0.95 (0.84, 1.07) 0.96 (0.85, 1.08) 0.565 0.396
MBzP 0.98 (0.87, 1.09) 0.94 (0.84, 1.05) 0.729 0.891
MCNP 0.95 (0.82, 1.10) 0.91 (0.79, 1.05) 0.392 0.797
MCOP 0.95 (0.81, 1.10) 0.92 (0.78, 1.09) 0.638 0.790
MCPP 0.91 (0.80, 1.04) 0.91 (0.79, 1.05) 0.157 0.252
ΣDEHPd 1.04 (0.88, 1.22) 1.02 (0.87, 1.19) 0.002** 0.783
MECPP 1.05 (0.89, 1.24) 1.02 (0.87, 1.20) 0.004** 0.855
MEHHP 1.03 (0.89, 1.18) 1.01 (0.88, 1.16) 0.002** 0.643
MEHP 1.01 (0.85, 1.20) 1.01 (0.85, 1.20) 0.000*** 0.909
MEOHP 1.02 (0.88, 1.19) 1.01 (0.87, 1.16) 0.004** 0.852
MEP 1.10 (0.99, 1.23) 1.09 (0.98, 1.21) 0.177 0.033*
Methyl Paraben 1.00 (0.94, 1.07) 1.00 (0.94, 1.07) 0.861 0.576
MHBP 1.02 (0.89, 1.16) 1.02 (0.89, 1.17) 0.486 0.488
MHiBP 1.04 (0.88, 1.23) 1.04 (0.88, 1.24) 0.426 0.920
MiBP 1.02 (0.87, 1.19) 1.01 (0.86, 1.19) 0.955 0.671
MMP 1.05 (0.93, 1.19) 1.08 (0.97, 1.22) 0.017* 0.262
Propyl Paraben 0.99 (0.92, 1.05) 0.99 (0.93, 1.05) 0.495 0.160
Triclosan 0.98 (0.90, 1.07) 1.00 (0.92, 1.08) 0.956 0.033*
aAccelerated failure time model adjusting for BMI Z-score, and maternal education
bp-value for interaction between continuous biomarker concentration and Tanner stage at biomarker measurement in adjusted models
cp-value for interaction between continuous biomarker concentration and BMI Z-score in adjusted models
dunits in log(nmol/l) reflecting the log transformed summation of DEHP metabolite concentrations
*p < 0.05, **p < 0.01, ***p < 0.001
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tertiles of monobenzyl phthalate (MBzP) across puberty
(Table 3; Fig. 1). While there was a later age of menarche
among the second tertile of MBzP relative to the first (HR:
0.70; 95% CI: 0.54, 0.93), the highest tertile was not signifi-
cantly different from the lowest (Table 3; Fig. 1).
Increased B1 concentrations of 2,5-dichlorophenol and
benzophenone-3 were associated with decreased time to
menarche (Table 4). In contrast, higher B1 concentra-
tions of the DEHP biomarkers mono(2-ethyl-5-hydroxy-
hexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)
phthalate (MEOHP), and mono(2-ethylhexyl) phthalate
(MEHP) were associated with later menarche (Table 4).
Girls in the highest tertile of B1 2,5-dichlorophenol con-
centration had an earlier age of menarche compared to
Table 3 Menarche hazard ratio (95% CI) between tertiles of each EDC biomarker across pubertya
Biomarker Middle vs Lowest Tertile Highest vs Middle Tertile Highest vs Lowest Tertile Trendb (p-value)
2,4-Dichlorophenol 1.03 (0.79, 1.35) 1.01 (0.79, 1.30) 1.04 (0.80, 1.37) 0.701
BPA 1.06 (0.81, 1.38) 0.86 (0.67, 1.11) 0.91 (0.70, 1.20) 0.695
MBP 0.95 (0.74, 1.23) 1.00 (0.76, 1.31) 0.95 (0.69, 1.31) 0.749
MBzP 0.70* (0.54, 0.93) 1.16 (0.88, 1.55) 0.82 (0.62, 1.08) 0.155
MCNP 0.99 (0.77, 1.27) 0.91 (0.67, 1.23) 0.89 (0.67, 1.19) 0.433
MCOP 0.94 (0.72, 1.22) 0.99 (0.75, 1.30) 0.93 (0.68, 1.27) 0.661
MCPP 0.92 (0.67, 1.26) 0.84 (0.63, 1.13) 0.77 (0.57, 1.04) 0.116
MEP 1.00 (0.74, 1.34) 1.20 (0.88, 1.62) 1.19 (0.90, 1.57) 0.212
Methyl Paraben 0.96 (0.71, 1.29) 1.14 (0.84, 1.54) 1.09 (0.81, 1.47) 0.575
MHBP 0.94 (0.72, 1.23) 1.10 (0.88, 1.39) 1.04 (0.76, 1.41) 0.808
MHiBP 0.98 (0.76, 1.26) 1.09 (0.86, 1.39) 1.07 (0.82, 1.39) 0.654
MiBP 0.85 (0.63, 1.15) 1.13 (0.85, 1.50) 0.96 (0.74, 1.26) 0.763
Propyl Paraben 0.83 (0.60, 1.13) 1.20 (0.85, 1.68) 0.99 (0.73, 1.33) 0.918
Triclosan 0.85 (0.66, 1.10) 1.05 (0.84, 1.30) 0.90 (0.67, 1.20) 0.536
aAccelerated failure time model adjusting for BMI Z-score and maternal education; restricting to the subset of associations for which there was no significant inter-
action between Tanner stage at biomarker measurement and biomarker concentration on timing of menarche (p > 0.05)
bTrend evaluated by modeling the log(median) concentration within tertiles as a continuous variable
*p < 0.05, **p < 0.01, ***p < 0.001
Fig. 1 Median menarcheal age (95% CI) between tertiles of EDC biomarker concentrations across Tanner stages. Significant difference (p < 0.05)
between: tertiles 1 and 2 indicated by A, tertiles 2 and 3 indicated by B, and tertiles 1 and 3 indicated by C
Binder et al. Environmental Health  (2018) 17:32 Page 5 of 11
those in the lowest tertile (Table 5; HR: 1.58; 95% CI: 1.
09, 2.29), corresponding to 4.09 months earlier median
age of menarche (Fig. 2). The influence of
benzophenone-3 and the DEHP metabolites on the rela-
tive time to menarche was less linear (Table 5; Fig. 2).
The median age of menarche was 4.10 months earlier
among girls in the second tertile of B1 benzophenone-3
concentration compared to the lowest tertile (HR: 1.58;
95% CI: 1.12, 2.22), but the change in timing was not
significant between the lowest and highest tertiles (Table
5). For all of the secondary oxidative DEHP biomarkers
quantified (MEHHP, MECPP, and MEOHP), the median
age of menarche was 6.57 to 7.37 months later among
girls in the middle tertile relative to those in the lowest
tertile of B1 concentration (Table 5). For MEHHP, girls
in the highest tertile at B1 also had a significantly later
age of menarche, but the median delay was not as great
as that among girls in the second tertile (Table 5; Fig. 2).
A log(ng/ml) increase in B4 concentrations of MMP
was associated with a faster time to menarche (Table 4;
Table 4 Menarche hazard ratio (95% CI) associated with log(ng/ml)
increase in biomarker stratified by Tanner stagea
Tanner Stage
Biomarker B1 B4
2,5-Dichlorophenol 1.13* (1.01, 1.27) 0.96 (0.85, 1.08)
Benzophenone-3 1.17** (1.06, 1.29) 0.99 (0.91, 1.06)
ΣDEHPb 0.77* (0.60, 0.98) 1.24 (0.97, 1.57)
MECPP 0.79 (0.61, 1.01) 1.24 (0.97, 1.58)
MEHHP 0.77* (0.62, 0.96) 1.22 (0.98, 1.51)
MEHP 0.80* (0.65, 0.98) 1.20 (0.98, 1.47)
MEOHP 0.78* (0.63, 0.97) 1.20 (0.96, 1.50)
MMP 0.96 (0.81, 1.14) 1.30** (1.10, 1.53)
aAccelerated failure time model adjusting for BMI Z-score and maternal educa-
tion; including an interaction between Tanner stage at biomarker measure-
ment and concentration; restricted to subset of associations for which the
interaction with the timing of biomarker measurement was
significant (p < 0.05)
bunits in log(nmol/l) reflecting the log transformed summation of DEHP
metabolite concentrations
*p < 0.05, **p < 0.01, ***p < 0.001
Table 5 Menarche hazard ratio (95% CI) between tertiles of biomarker stratified by Tanner stage at measurementa
Biomarker Tanner Stage Middle vs Lowest Tertile Highest vs Middle Tertile Highest vs Lowest Tertile Trendb (p-value)
2,5-Dichlorophenol
1 1.35 (0.93, 1.98) 1.17 (0.81, 1.68) 1.58* (1.09, 2.29) 0.019*
4 1.16 (0.79, 1.69) 0.79 (0.55, 1.14) 0.91 (0.62, 1.35) 0.521
Benzophenone-3
1 1.58** (1.12, 2.22) 0.89 (0.60, 1.34) 1.41 (0.96, 2.06) 0.142
4 0.87 (0.61, 1.24) 1.07 (0.74, 1.54) 0.93 (0.63, 1.37) 0.743
ΣDEHP
1 0.43*** (0.31, 0.61) 1.56* (1.09, 2.25) 0.67* (0.46, 0.98) 0.140
4 0.93 (0.64, 1.36) 1.52* (1.01, 2.28) 1.42 (0.93, 2.17) 0.083
MECPP
1 0.43*** (0.30, 0.62) 1.63** (1.15, 2.33) 0.71 (0.47, 1.05) 0.232
4 0.92 (0.64, 1.34) 1.53* (1.02, 2.31) 1.41 (0.93, 2.15) 0.082
MEHHP
1 0.47*** (0.33, 0.68) 1.44 (1.00, 2.09) 0.68* (0.47, 0.99) 0.064
4 1.05 (0.73, 1.52) 1.29 (0.87, 1.90) 1.36 (0.89, 2.06) 0.148
MEHP
1 0.78 (0.54, 1.14) 0.94 (0.64, 1.38) 0.73 (0.50, 1.09) 0.122
4 1.05 (0.74, 1.49) 1.40 (0.93, 2.10) 1.47 (0.98, 2.20) 0.061
MEOHP
1 0.43*** (0.30, 0.62) 1.92*** (1.34, 2.75) 0.83 (0.59, 1.17) 0.313
4 1.07 (0.73, 1.55) 1.30 (0.87, 1.95) 1.39 (0.91, 2.12) 0.120
MMP
1 1.31 (0.89, 1.93) 0.82 (0.55, 1.22) 1.07 (0.74, 1.56) 0.672
4 0.98 (0.68, 1.42) 1.45* (1.01, 2.10) 1.42* (1.02, 1.99) 0.032*
aEstimating Tanner stage-specific association between biomarker and age of menarche adjusting BMI Z-score and maternal education, including an interaction between
biomarker tertile and Tanner stage; restricted to subset of associations for which the interaction with Tanner stage was significant (p < 0.05)
bTrend evaluated by modeling the log(median) concentration within tertiles as a continuous variable
*p < 0.05, **p < 0.01, ***p < 0.001
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HR: 1.30; 95% CI: 1.10, 1.53). The influence of B4 con-
centrations of MMP on the age of menarche was rela-
tively linear. Among girls in the highest B4
concentration tertile, the median age of menarche was 3.
15 months earlier than girls in the lowest MMP tertile
(Table 5; HR: 1.42; 95%: 1.02, 1.99).
For MEP and triclosan, the influence on the age of me-
narche was significantly modified by age and sex-adjusted
BMI Z-score (Table 2). The average effect of triclosan
across various body sizes was negligible, whereas there
was a shift towards earlier menarche among girls with
higher concentrations of MEP (Table 2). Stratifying by
BMI category, a log(ng/ml) increase in triclosan concen-
tration was associated with earlier age of menarche
(Table 6; HR: 1.16; 95% CI: 1.01, 1.34) among girls that
were either overweight or obese (≥85th percentile BMI
Z-score). Similarly, a log(ng/ml) increase in MEP among
overweight or obese girls was associated with earlier me-
narche (HR: 1.24; 95%CI: 1.05, 1.47), with the median age
of menarche 5.03 months earlier in the highest compared
to the lowest tertile (Fig. 3).There was no significant asso-
ciation with either triclosan or MEP among girls that were
normal weight.
Discussion
In this study, we report changes in the timing of menar-
che associated with earlier childhood and adolescent bio-
marker urinary concentrations of several phthalates and
phenols. For most of these biomarkers, the strength of
the association was dependent on the timing of bio-
marker measurement, suggesting specific periods of sus-
ceptible hormone-driven development. High childhood
(Tanner 1) urinary concentrations of DEHP metabolites
were associated with later menarche. In contrast, in-
creased childhood levels of 2,5-dichlorophenol and
benzophenone-3 were associated with early menarche.
Increased adolescent (Tanner 4) concentrations of MMP
were similarly associated with earlier menarche. This
sensitivity to exposure window may partially explain
some discordance between prior studies of childhood
EDC exposure and the age of menarche, which evaluated
biomarker concentrations at various ages [25–28].
Among this cohort of Latina girls, increased urinary
concentrations of DEHP biomarkers during childhood
were associated with later menarcheal age. High pre-
pubertal concentrations of these biomarkers have been
associated with decreased concentrations of adolescent
androgens, suggesting DEHP may inhibit adrenal andro-
gen synthesis in humans [29]. This anti-androgenic in-
fluence of DEHP is further supported by the later age of
pubarche among girls with relatively high concentrations
Fig. 2 Median menarcheal age (95% CI) between tertiles of EDC biomarker concentrations stratified by Tanner stage
Table 6 Menarche hazard ratio (95% CI) associated with log(ng/ml)
increase of biomarker stratified by BMI percentilea
BMI Percentile
Biomarker <85th ≥85th
MEP 1.02 (0.90, 1.17) 1.24* (1.05, 1.47)
Triclosan 0.93 (0.84, 1.02) 1.16* (1.01, 1.34)
aAccelerated failure time model adjusting for BMI Z-score and maternal education;
restricted to subset of associations for which the interaction with BMI Z-score was
significant (p < 0.05)
*p < 0.05, **p < 0.01, ***p < 0.001
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of DEHP metabolites [42, 43]. Another mechanism by
which childhood DEHP exposure may influence pubertal
timing is through its influence on concentrations of
IGF-1 and thyroid hormones [44–47]. DEHP may also
act by modifying the production of luteinizing hormone
and follicle-stimulating hormone, reducing estrogen for-
mation, or through the activation of peroxisome
proliferation-activated receptors [48]. Similar to our
findings, one longitudinal study of German adolescents
recently reported that higher urinary concentrations of
DEHP metabolites from ages 8–10 years were associated
with decreased odds of having reached menarche at sub-
sequent visits [30]. Other studies have not reported the
same association between urinary DEHP biomarker con-
centrations and age of menarche. A cross-sectional study
of U.S. girls 12–16 years reported the summation of
phthalate urinary biomarker concentrations was not as-
sociated with the onset of menarche [27]. A smaller
cross-sectional study of Hispanic girls in Mexico City
also did not report a significant influence of these expo-
sures [28]. In contrast, greater concentrations of DEHP
biomarkers between 7 and 15 years were associated with
increased odds of earlier menarche within a cohort of
Chinese girls [26]. Our study results suggest that the in-
fluence of the biomarkers was modified by pubertal stage
at the time of exposure assessment, and suggested the
correlation in DEHP biomarker concentrations across
puberty was weak. Therefore, these disparate findings
may partially reflect differences in exposure window.
In contrast to the influence of the DEHP biomarkers,
increased concentrations of 2,5-dichlorophenol,
benzophenone-3, and MMP were associated with earlier
menarche. 2,5-dichlorophenol is the major biomarker of
para-dichlorobenzene, a chemical used in moth repel-
lants, room deodorants, and fumigants. Two prior stud-
ies of U.S. girls reported a similar association between
2,5-dichlorophenol and age of menarche, which is con-
sistent with the estrogenic activity 2,5-dichlorophenol
has demonstrated in vitro and in vivo [25, 27, 49]. The
sunscreen agent benzophenone-3 has also been shown
to have estrogenic characteristics, including exerting
uterotrophic effects in rats, simulating proliferation of
breast cancer cell lines, as well as binding and activating
estrogen receptors [50, 51]. While these compounds
may have a similar mechanism of action, prior studies
did not report a significant association between
benzophenone-3 and menarcheal age [25, 27]. In our
study, only pre-pubertal concentrations of 2,5-dichloro-
phenol and benzophenone-3 were associated with earlier
menarche. Conversely, MMP concentrations close to the
onset of menarche were associated with earlier timing.
Two studies of Chinese girls reported conflicting associ-
ations between MMP concentrations and pubertal tim-
ing [52, 53]. The parent compound of MMP, dimethyl
phthalate (DMP), can be found in insect repellants and
plastics. While no estrogenic effect of DMP has been
demonstrated in vivo, concentrations of MMP among
children 5–7 years have been inversely associated with
concentrations of IGF-1, with no significant impact on
thyroid function [54]. The potential influence on the
regulation of growth and development suggests the need
for further investigation into the impact of MMP, or its
precursor DMP, on adolescent development.
BMI significantly modified the influence of both MEP
and triclosan on age of menarche. An increase in either
biomarker was only associated with earlier menarche
among girls that were either overweight or obese.
Among U.S. children, neither association was signifi-
cantly modified by BMI; however, the association with
MEP was in a similar direction among all girls [25, 27].
It is possible that these differences in effect modification
by BMI are due to race/ethnicity disparities in adoles-
cent body composition [55]. Compared to white U.S.
girls, Asian and Hispanic adolescents have greater trunk
fat placement independent of total body fat [55].
Furthermore, Hispanic girls tend to have higher percent
body fat than white girls, adjusting for body size [56]. It
is possible the action of MEP and triclosan may be
Fig. 3 Median menarcheal age (95% CI) between tertiles of EDC biomarker concentrations stratified by BMI percentile
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modified by elements of metabolic profile shaped by fat
distribution, such as modulations in insulin resistance or
leptin production [18, 57]. Alternatively, the observed
statistical interaction with BMI may reflect an influence
of MEP and triclosan on both adiposity and menarcheal
age. Prenatal exposure to MEP has been associated with
decreased childhood BMI Z-score [23], but this associ-
ation has been inconsistent across populations [22]. In
one cross-sectional study, triclosan exposure was simi-
larly associated with a decrease in BMI and waist cir-
cumference among children [58], but this correlation
was not observed in a second cross-sectional study [38].
Given the impact of childhood adiposity on pubertal
timing [59–63], the potential influence of EDCs on adi-
posity raises important consideration of the direction of
causation. Specifically, EDC exposure could have a direct
effect on menarcheal age, or influence adiposity to im-
pact pubertal timing, or influence pubertal timing to im-
pact adiposity. These theories are not mutually
exclusive, and should be addressed by follow-up studies.
One limitation to this study is that we cannot account
for the influence of earlier EDC exposure on pubertal
timing that may have partially confounded the observed
associations due to consistent home environment. For
example, there is indication that exposure to certain
EDCs in utero, such as DEHP, may influence both child-
hood adiposity and pubertal timing [21–23, 28]. A sec-
ond limitation is that while this study did measure
urinary biomarkers at two developmental time points,
concentrations in a single spot urine may not be repre-
sentative of average exposure. Nonetheless, prior longi-
tudinal assessments of EDC concentrations suggest that
spot measurements can estimate relative EDC exposures
over the course of several months to a year due to recur-
rent exposures [64–67]. A third important consideration
is that these girls were primarily from low socioeco-
nomic status families, which may have an exposure pro-
file that is not representative of all children and
adolescents. However, given the faster decline in menar-
cheal age among impoverished girls [6, 8, 9, 14, 15], the
determinants of pubertal timing within this subset of the
population is of particular public health concern. Finally,
this study did not account for potential synergistic or
antagonistic impacts of EDC co-exposures on pubertal
timing. In addition to the studied biomarkers, exposure
to other types of unmeasured EDCs, such as persistent
organic pollutants, may have modified our observed
associations with pubertal development. These interac-
tions may contribute to the lack of reproducibility in the
associations between EDC biomarkers and the onset of
menarche across populations. Given the concurrence of
EDCs in consumer products and the home environment
[68], it is difficult to disentangle the independent influ-
ence of any single chemical on menarcheal age.
However, we hope these findings spur additional re-
search into modifiable sources of EDC exposure during
childhood and adolescence.
Conclusions
Exposure to certain phenols and phthalates during spe-
cific stages of pubertal development was associated with
menarcheal age in Chilean girls. This study highlights
the necessity of capturing critical windows of exposure
during periods of rapid physiological change. Addition-
ally, the unique associations observed in this cohort
emphasize the need to integrate investigations from
across the world to identify population-specific sensitiv-
ities, which can guide global health recommendations.
As data collection in this longitudinal cohort continues,
we plan to explore the impact of EDC exposure on add-
itional facets of pubertal development, such as the onset
of regular cycling. These shifts in pubertal timing may
have both immediate psychological implications for
these girls, and may indicate changes in the predispos-
ition to adverse health in adulthood. Girls with early pu-
berty have been shown to suffer from higher rates of
adolescent depression, anxiety, and delinquent behavior
[69–72]. Early onset of menarche has also been associ-
ated with increased risk of type-2 diabetes, cardiovascu-
lar disease, and cancer risk. Future studies will be
necessary to directly link the variation in pubertal timing
associated with early life EDC exposure to adult health,
as well as the potential direct effect of childhood/adoles-
cent EDC exposure on adult health independent of age
of menarche.
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